Your browser doesn't support javascript.
loading
Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1.
Gartland, Margaret; Cahn, Pedro; DeJesus, Edwin; Diaz, Ricardo Sobhie; Grossberg, Robert; Kozal, Michael; Kumar, Princy; Molina, Jean-Michel; Mendo Urbina, Fernando; Wang, Marcia; Du, Fangfang; Chabria, Shiven; Clark, Andrew; Garside, Louise; Krystal, Mark; Mannino, Frank; Pierce, Amy; Ackerman, Peter; Lataillade, Max.
Afiliação
  • Gartland M; ViiV Healthcare, Research Triangle Park, North Carolina, USA.
  • Cahn P; Fundación Huesped, Buenos Aires, Argentina.
  • DeJesus E; Orlando Immunology Center, Orlando, Florida, USA.
  • Diaz RS; Infectious Diseases Division, Paulista School of Medicine, Federal University of São Paulo, São Paulo, Brazil.
  • Grossberg R; Montefiore Medical Center, Bronx, New York, USA.
  • Kozal M; Department of Internal Medicine, Infectious Diseases Section, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Kumar P; Department of Medicine and Microbiology, Georgetown University Medical Center, Washington, DC, USA.
  • Molina JM; University of Paris, Saint-Louis and Lariboisière Hospitals, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Mendo Urbina F; Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru.
  • Wang M; GlaxoSmithKline, Collegeville, Pennsylvania, USA.
  • Du F; GlaxoSmithKline, Collegeville, Pennsylvania, USA.
  • Chabria S; ViiV Healthcare, Branford, Connecticut, USA.
  • Clark A; ViiV Healthcare, Brentford, United Kingdom.
  • Garside L; GlaxoSmithKline, Brentford, United Kingdom.
  • Krystal M; ViiV Healthcare, Branford, Connecticut, USA.
  • Mannino F; GlaxoSmithKline, Collegeville, Pennsylvania, USA.
  • Pierce A; ViiV Healthcare, Research Triangle Park, North Carolina, USA.
  • Ackerman P; ViiV Healthcare, Branford, Connecticut, USA.
  • Lataillade M; ViiV Healthcare, Branford, Connecticut, USA.
Antimicrob Agents Chemother ; 66(6): e0175121, 2022 06 21.
Article em En | MEDLINE | ID: mdl-35502922

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Organofosfatos / Piperazinas / Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Farmacorresistência Viral Múltipla Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Organofosfatos / Piperazinas / Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Farmacorresistência Viral Múltipla Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article